DJIA 16,351.38 293.03 1.82%
NASDAQ 4,749.98 113.87 2.46%
S&P 500 1,948.86 35.01 1.83%
market minute promo

39.28 2.24 (6.05%)

Quote as of


company name or ticker

Recent Quotes

ENTA $39.28 6.05%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $37.43
Previous Close $37.04
Daily Range $36.90 - $39.40
52-Week Range $30.13 - $52.58
Market Cap $735.1M
P/E Ratio 10.46
Dividend (Yield) $0.00 (0.0%)
Volume 187,243
Average Daily Volume 381,659
Current FY EPS $4.15

Sector

Industry

Enanta Pharmaceuticals, Inc. (ENTA) Description

Enanta Pharmaceuticals, Inc. Website: http://www.enanta.com/

News & Commentary

Here's Why Enanta Pharmaceuticals Stock Beat the Downtrend in July

Enanta Pharmaceuticals was one of the few strong performers in the healthcare sector last month. Here's why.

The Best Deals in Under-the-Radar Stocks

Anyone can buy a household brand-name stock, but sometimes the best gems fly under Wall Street's radar.

Enanta Pharmaceuticals' (ENTA) CEO Jay Luly on Q2 2015 Results - Earnings Call Transcript

Why Earnings Season Could Be Great for Enanta Pharmaceuticals (ENTA) - Tale of the Tape

Why Earnings Season Could Be Great for Enanta Pharmaceuticals (ENTA) - Tale of the Tape

Enanta Pharmaceuticals (ENTA) Jumps: Stock Rises 5.1% - Tale of the Tape

Enanta Pharmaceuticals (ENTA) Jumps: Stock Rises 5.1% - Tale of the Tape

Enanta Pharmaceuticals (ENTA) Flagged As Strong On High Volume

Enanta Pharmaceuticals Announces U.S. Regulatory Approval of TECHNIVIE (ombitasvir, paritaprevir and

Enanta Pharmaceuticals Announces U.S. Regulatory Approval of TECHNIVIE (ombitasvir, paritaprevir and ritonavir) tablets

Insider Trading Alert - ENTA, BFS And PAYX Traded By Insiders

Short-Sellers Betting Against These Biotechs

5 Free Cash All-Stars With Guru Strategy Approval

See More ENTA News...